Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Institutul National De Boli Infectioase Prof.Dr.Matei Bals

Research site

Romania Strada Dr. Calistrat Grozovici Nr. 1, 021105 Bucharest, Romania

  • 9 trials recruiting
  • Hepatitis D · Chronic hepatitis B · HIV infection
  • Adults and children

About Specializations

Institutul National De Boli Infectioase Prof.Dr.Matei Bals in Bucharest, Romania specialises in clinical trials of conditions such as Hepatitis D, Chronic hepatitis B, HIV infection, Hepatitis B, and other specialisations. This site conducts important research.

Main research areas of the site

Virus Diseases Research

At Institutul National De Boli Infectioase Prof.Dr.Matei Bals in Bucharest, the clinical trial portfolio focuses on virus diseases, with studies centered on COVID-19, chronic hepatitis B, chronic hepatitis D, and HIV-1. The research is designed to assess new treatments, understand antiviral effects, and support better management of infectious diseases.

  • Studies in COVID-19 are evaluating whether new outpatient treatments can reduce hospitalization and death.
  • Chronic hepatitis B research includes testing antiviral options in children, adolescents, and adults to improve safety and infection control.
  • Chronic hepatitis D infection studies are examining treatment safety and the longer-term impact on liver disease progression.
  • HIV-1 research is exploring new approaches aimed at expanding future antiviral treatment choices.

Overall, the site supports clinical research that combines antiviral therapy evaluation with efforts to improve disease outcomes across a range of serious viral infections.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Dr. Calistrat Grozovici Nr. 1021105 BucharestRomania
Open in maps ↗
Recruiting now
9 trials
Conditions studied
13

More sites in BucharestRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

30 clinical trials

COVID-19

Recruiting

A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Molnupiravir
  • Sponsor:Merck Sharp & Dohme LLC

Acute respiratory failure

Recruiting

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Hepatitis D

Recruiting

A study comparing brelovitug to bulevirtide for treating chronic hepatitis delta infection in patients currently receiving bulevirtide

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BJT-778
  • Sponsor:Mirum Pharmaceuticals Inc.

Hepatitis D+1

Recruiting

Study of GS-4321 for Healthy People and Patients With Chronic Hepatitis Delta Virus Infection

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:GS-4321
  • Sponsor:Gilead Sciences Inc.

Chronic hepatitis B

Recruiting

Study comparing ALG-000184 with tenofovir disoproxil in untreated adults with chronic hepatitis B virus infection

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:ALG-000184
  • Sponsor:Aligos Therapeutics Inc.

Hepatitis D

Recruiting

Clinical Trial for Patients with Chronic Hepatitis D: Comparing Brelovitug and Bulevirtide Treatments

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BJT-778
  • Sponsor:Mirum Pharmaceuticals Inc.

Clostridium difficile infection

Recruiting

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
  • Sponsor:Vedanta Biosciences Inc.

Pneumonia

Recruiting

Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Baloxavir Marboxil
  • Sponsor:University Of Oxford

Diabetic foot infection

Recruiting

Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Micurx Pharmaceuticals Inc.

HIV infection

Not yet recruiting

Safety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Gilead Sciences Inc.

HIV infection

Not yet recruiting

Study of Fostemsavir in Adults with HIV Transitioning from Prior ViiV Clinical Trials for Continued Treatment Access

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Fostemsavir
  • Sponsor:Viiv Healthcare UK Limited

Chronic hepatitis B

Not yet recruiting

Study of Tenofovir Alafenamide for Children and Teens with Chronic Hepatitis B

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Tenofovir Alafenamide
  • Sponsor:Gilead Sciences Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.